Namshik Han

IBS Professor

Yonsei University
Country flagSouth Korea

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (5)

Motivation Long COVID is a multisystem condition characterized by persistent symptoms such as fatigue, cognitive impairment, and systemic inflammation, following COVID-19 infection. However, its mechanisms remain poorly understood. In this study, we applied the quantum walk, a computational approach leveraging quantum interference, to explore large-scale SARS-CoV-2–induced protein networks. Result Compared to the conventional random walk with restart method, the quantum walk demonstrated superior capacity to traverse deeper regions of the network, uncovering proteins and pathways implicated in Long COVID. Key findings include mitochondrial dysfunction, thromboinflammatory responses, and neuronal inflammation as central mechanisms. Quantum walk uniquely identified the CDGSH iron-sulfur domain-containing protein family and VDAC1, a mitochondrial calcium transporter, as critical regulators of these processes. VDAC1 emerged as a potential biomarker and therapeutic target, supported by FDA-approved compounds such as cannabidiol. These findings highlight quantum walk as a powerful tool for elucidating complex biological systems and identifying novel therapeutic targets for conditions like Long COVID. Availability and implementation The code and input data that were used for this study are available at https://github.com/Namshik-Han-Lab/QuantumWalk-LongCovid.

Year:

2026

Year:

2026

Drug discovery requires understanding disease mechanisms, making the integration of multi-modal data essential. These data types, including omics, disease-associated, and pathway information, must be combined to uncover therapeutic insights. We developed iPANDDA, a computational pipeline that integrates these data through a network-based approach to predict candidate drug targets for specific diseases. We applied iPANDDA to lung squamous cell carcinoma (LUSC), a subtype of non-small cell lung cancer representing ~25% of global cases. Despite advances in cancer therapeutics, targeted treatments for LUSC remain limited, partly due to a lack of robust models to study carcinogenesis and therapeutic response. The SOX2 gene, amplified in ~50% of patients, plays a critical role in sustaining the cancer phenotype. Using iPANDDA, we identified and validated SOX2-dependent therapeutic targets. In vitro inhibition studies confirmed AKT and mTOR complexes as key monotherapy and combination therapy targets and revealed pathways for SOX2-targeted combination therapies.

Year:

2025

Background: Lower respiratory tract infection (LRTI) is a leading cause of morbidity and mortality among children admitted to paediatric intensive care units (PICUs). Accurate diagnosis is complicated by the breadth the broad spectrum of pathogens involved and the overlap of symptoms with non-infectious respiratory problems, often leading to diagnostic delays. This study aimed to identify early diagnostic biomarkers and characterise microbial-host interactions in paediatric LRTI. Methods: We re-analysed a metagenomic next-generation sequencing (mNGS) dataset from 261 PICU patients with acute respiratory failure, combining microbial and host transcriptomic profiles using differential expression, network, and machine-learning approaches. Candidate biomarkers were validated in an independent prospective cohort of 100 critically ill children (RASCALS), with non-bronchoscopic bronchoalveolar lavage (mini-BAL), blood cytokine profiling, and pathogen detection. Findings: Respiratory syncytial virus (RSV) and Haemophilus influenzae were the most enriched pathogens in LRTI cases. Host transcriptomics revealed activation of cytokine and chemokine signalling pathways. A seven-gene panel (IRF7, FFAR3, GZMB, FABP4, FN1, CXCL5, BCAR1) achieved high diagnostic accuracy, comparable to a published 14-gene model. In RASCALS, RSV detection combined with mini-BAL IL-8 or blood IL-4:TRAIL ratio improved diagnostic accuracy (71%) and correlated with ventilator-free days. Plasma C-reactive protein (CRP) and IL-6 further discriminated bacterial from non-bacterial infections (AUC 0.81 and 0.74, respectively). Interpretation: Integrating host and microbial markers provides a feasible route to early, accurate diagnosis of paediatric LRTI. The identified 7-gene panel and cytokine markers could be translated into PCR- or ELISA-based bedside assays to support rapid clinical decision-making and antimicrobial stewardship in PICU.

Year:

2025

Year:

2023

Collaborators (6)

Woochang Hwang

-

UNITED KINGDOM
View details

Gehad Youssef

University of Cambridge

UNITED KINGDOM
View details

Kourosh Saeb-Parsy

Reader

University of Cambridge

UNITED KINGDOM
View details

Dariusz Gorecki

Academic, Professor, Professor of Molecular Medicine

University of Portsmouth

UNITED KINGDOM
View details

Michal Korostynski

Institute of Pharmacology

POLAND
View details

Matthias Zilbauer

University of Cambridge

UNITED KINGDOM
View details